History

2024-12

2nd Cryo-EM Workshop 2024 by BaobabAiBio

2024-07

Research service contract with JW C&C Research Laboratories

2024-03

1st Cryo-EM Workshop 2024 by BaobabAiBio

2024-02

Research service contract with KDCA

2023-10

Attended AACR-NCI-EORTC 2023

2023-06

Attended BIO 2023 International Convention (BIO USA 2023)

2023-04

Research Service Contract with Samsung Bioepis

2022-07

Research service contract with Inventage Lab

2022-04

Research service contract with LG Chem

2022-01

Cryo-EM Platform Krios(300kV) Operation

2021-07

Research service contract with MirimGene

2021-06

Cryo-EM Platform Aquilios 2, Glacios(200kV) Operation

2021-05

Research service contract with eFlask

2021-02

Fund Raising (Series A)

2020-11

Selected for a National grant of Development of AI platform based first-in-class drug design to overcome drug-resistance of melanoma patients by Ministry of SMEs and Start Ups

2020-10

Selected for a National grant of Drug development of colon cancer and rare diseases using artificial intelligence platforms by Ministry of SMEs and Start Ups

2020-08

Certified as a Venture Business Company

2020-04

Move to Yonsei University International Campus at Songdo Incheon

2020-04

Establishment of Company R&D Center

2020-04

Company name changed to BaobabAiBIO Co., Ltd.

2020-03

Selected for BIG3(Bio, Health) Project by Ministry of SMEe and Startups

2019-11

Inauguration of CEO In Sang Lee and CTO Kyoung Tai No(Each Representative)

2019-04

Fund Raising from GenoFocus (Seed)

2018-07

Selected for a National grant of Bio-SPC for development of therapeutic agents by Ministry of Science & ICT

2018-04

Inauguration of CEO Kyoung Tai No

2018-04

Establishment of Baobab Pharm Co., Ltd at Yonsei University Seoul Korea